Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-31 2026-03-31 true The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2 false 2025-04-01 property 2 true false 8293360 2025-03-31 8293360 2024-04-01 2025-03-31 8293360 c:CurrentFinancialInstruments c:WithinOneYear 2025-03-31 8293360 c:CurrentFinancialInstruments c:WithinOneYear 2026-03-31 8293360 2026-03-31 8293360 6 2025-04-01 2026-03-31 8293360 2025-04-01 2026-03-31 8293360 c:ShareCapital 2025-03-31 8293360 c:ShareCapital 2026-03-31 8293360 c:RetainedEarningsAccumulatedLosses 2025-03-31 8293360 c:RetainedEarningsAccumulatedLosses 2026-03-31 8293360 d:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 8293360 d:FullAccounts 2025-04-01 2026-03-31 8293360 d:FRS102 2025-04-01 2026-03-31 8293360 d:Director4 2025-04-01 2026-03-31 8293360 c:CurrentFinancialInstruments 2025-03-31 8293360 c:CurrentFinancialInstruments 2026-03-31 8293360 d:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 8293360 e:PoundSterling 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Registered number: 8293360 DINNINGTON GP PHARMA LIMITED UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026
DINNINGTON GP PHARMA LIMITED REGISTERED NUMBER: 8293360 BALANCE SHEET AS AT 31 MARCH 2026
|  | 2026 |  | 2025
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Investments | 4 |  | 60 |  | 60
|  |  | 60 |  | 60
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 5 | 1,210 |  | 1,210 |
Cash at bank and in hand |  | 1,473 |  | 1,694 |
|  | 2,683 |  | 2,904 |
Creditors: amounts falling due within one year | 6 | (1,093) |  | (1,231) |
Net current assets |  |  | 1,590 |  | 1,673
Total assets less current liabilities |  |  | 1,650 |  | 1,733
Net assets |  |  | 1,650 |  | 1,733
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 1,210 |  | 1,210
Profit and loss account |  |  | 440 |  | 523
|  |  | 1,650 |  | 1,733
Page 1
DINNINGTON GP PHARMA LIMITED REGISTERED NUMBER: 8293360 BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2026 The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 July 2026.
Dr Sampath Kumar Sukumar
Director
The notes on pages 3 to 4 form part of these financial statements. Page 2
DINNINGTON GP PHARMA LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026
1. | General information
Dinnington GP Pharma Limited is a private company limited by shares, incorporated in England and Wales (registered number: 08293360). The registered office is Anston Medical Centre, Quarry Lane, North Anston, Sheffield, S25 4DB. The principal activity of the Company continued to be a holding company of Dinnington Partnership Limited. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland ('FRS102') and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The Company's functional and presentation currency is pounds sterling. The following principal accounting policies have been applied:
| 2.2 | Going concern
The company continues to adopt the going concern basis in preparing its financial statements.
| 2.3 | Valuation of investments
Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.
| 2.4 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.5 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
| 2.6 | Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
3. | Employees
| The average monthly number of employees, including directors, during the year was 2 (2025 - 2).
Page 3
DINNINGTON GP PHARMA LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026
4. | Fixed asset investments
|  | Unlisted investments
|  | £
| Cost or valuation |
| At 1 April 2025 | 60
| At 31 March 2026 | 60
5. | Debtors
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| Called up share capital not paid | 1,210 | 1,210
6. | Creditors: Amounts falling due within one year
|  |  |  |  | 2026 | 2025
|  |  |  |  | £ | £
| Trade creditors | - | 258
| Other creditors | 373 | 373
| Accruals and deferred income | 720 | 600
|  | 1,093 | 1,231
Page 4